Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

FUSION Allergy – natural hay fever relief for a summer without the suffering!

For allergy sufferers looking for a more natural approach to hay fever relief this summer, the FUSION™ Allergy range is proven to be as effective as antihistamines at relieving allergic symptoms in the eyes (conjunctivitis), eyelids, and nose (rhinitis).

Containing the naturally occurring molecule, Ectoin®, the drug-free and preservative-free formula creates a protective barrier against allergens whilst moisturising the lining of the nose and reducing inflammation.

A summer marketing campaign – ‘Your natural phewww from hay fever’ – will focus on FUSION™ Allergy Nasal Spray and FUSION™ Allergy Eye Drops, with other products in the range including a Day & Night Eye Gel, Cooling Eye Mask and an Eye Spray.

Excluding the Eye Spray, all products are suitable for pregnant women and children of all ages.

SCOPE Healthcare 0808 175 3200

Topics

         
Qualified Pharmacy Assistant - Digital Pharmacy
Stoke-on-Trent, Staffordshire
£11.56 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD138203

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel